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The findings of the recent independent review of the UK Liverpool Care Pathway
(LCP)1, following substantial concerns raised by members of the public and health
professionals found that the implementation of the LCP is often associated with poor
care1. The Neuberger Report highlighted the complexity of various ethical, safety,
clinical practice and negligence issues associated with pathway usage and how,
despite technological advances, diagnosing dying continues to be challenging1. The
UK Government’s decision to phase out the LCP as policy following these findings,
has generated considerable debate both within and beyond the UK2. However, another
key issue raised by the Neuberger’s report is the issue of the palliative care
community’s perceived willingness to readily adopt new clinical practices in the
absence of evidence. It is this translational issue that this editorial explores.

In the thirty five years from 1970, the proportion of peer-reviewed publications in
palliative care in relation to all publications more than doubled3. Arguably the quality
has also improved, with one in every 122 controlled clinical trials ever published in
the literature as a whole being in palliative and supportive care4. Much of the
literature is distributed throughout a very large number of journals3, making the
process of assembling and synthesising the data an ongoing challenge. These findings
confirm the concerted effort that palliative care researchers are making into
continuing to build a strong evidence base for clinical practice and for public policy.

Despite these positive developments, the Neuberger report highlighted that nearly 10
years after its widespread dissemination, prospective testing of the LCP had yet to be
undertaken at a level of rigor sufficient to adequately support crucial national policy
decisions1. Several before and after studies have been conducted, reporting positive

effects of the LCP5-7. The common shortfalls of these studies variously included the
lack of control arms, data collection that was not contemporaneous and sampling that
lacked comparable groups8. Data from these studies can be seen as hypothesis
generating, allowing more refined design for subsequent rigorous investigations, but
should not be seen as definitive in and of themselves. Further, these data have been
complemented with a number of non-experimental studies (i.e. reviews, letters, audits,
case reports and qualitative studies) supporting the effectiveness of the LCP for
improving outcomes8, 9. Study designs and articles of this type, while useful, should
never be used to conclude effectiveness. Even when combined, this evidence should
not have been seen as sufficient to change practice at a national level anywhere
around the world.

The widespread adoption of the LCP in many countries suggests that there was a
willingness in the sector on this occasion to translate evidence into practice
prematurely8-10, while conversely it remains challenging for other high level evidence
from well conducted trials to be adopted efficiently11,

12

. It is speculative, yet

reasonable to assume that if high level evidence indicated that the LCP was truly
effective and where had been quantified so they could be mitigated, the current status
of LCP could have been different.

The limitations to conducting palliative and end-of-life care research are well
recognised, but these barriers should be viewed as challenges that require further
efforts to address effectively, rather than used as the rationale for settling for a lower
level of evidence upon which clinical practice and policy decisions are made. The
research team led by Costantini should be congratulated for their research program

investigating the effects of the LCP. This team sought to systematically develop
through a rigorous program of research that operationalise the Medical Research
Council (MRC) framework for evaluating complex interventions13-16.

The concepts of evidence-based medicine are less than two decades old. As such, how
do we as a global clinical community in palliative care support each other to develop
the requisite critical appraisal skills? This requires a whole-of-sector approach in
order to use the available evidence as effectively as possible. To achieve this,
palliative care should only be taught by those who have the clinical expertise as well
as the competency in evidence-based healthcare and critical appraisal skills. Palliative
care professionals must continue, where data are lacking, to find ways to improve the
evidence base by extending existing research to address current gaps in knowledge.
This asks a great deal of a clinical community that has come late to developing the
evidence that can underpin key decisions and implementing such knowledge
systematically17.
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